Lex/Who's lobbying/Pharmaceuticals & Life Sciences
EU lobbying · Pharmaceuticals & Life Sciences

Who lobbies the EU on Pharmaceuticals & Life Sciences?

Pharmaceutical and life-sciences companies face EU rules on medicines authorisation, clinical trials and supply-chain integrity across the single market. These are the EU acts most likely to apply.

Organisations27
Disclosed meetings47
SourceEC meeting disclosures
Matched onmedicinal products, clinical trials, orphan medicinal
In short

27 organisations appear across 47 disclosed European Commission meetings on pharmaceuticals & life sciences; the top listed organisations are AnimalhealthEurope, Access VetMed, European Federation of Pharmaceutical Industries and Associations. EC meeting disclosures Transparency Register

Where do you sit on pharmaceuticals & life sciences?
Run a free exposure scan — see the EU files heading your way and who else is in the room.

Who’s lobbying it

Ranked by distinct disclosed European Commission meetings whose topic matches pharmaceuticals & life sciences keywords. Every organisation links to the official disclosure.

Disclosed meetings

One recent disclosed Commission meeting per organisation, matched to pharmaceuticals & life sciences by topic — each linked to its source.

DateOrganisationDisclosed topic
2026-06-19AnimalhealthEuropeHybrid Meeting with industry stakeholders on the implementation of the Regulation on veterinary medicinal products (Regulation (EU) 2019/6) source ↗
2026-06-19Access VetMedHybrid Meeting with industry stakeholders on the implementation of the Regulation on veterinary medicinal products (Regulation (EU) 2019/6) source ↗
2025-02-18European Federation of Pharmaceutical Industries and AssociationsCompetitiveness of the innovative pharmaceutical sector, with specific focus on clinical trials and biotech act. source ↗
2026-02-17European Organisation for Research and Treatment of CancerClinical trials source ↗
2026-07-29Irish Farmers' AssociationExchange of views on the EU legislation as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union source ↗
2026-06-19Association of Veterinary ConsultantsHybrid Meeting with industry stakeholders on the implementation of the Regulation on veterinary medicinal products (Regulation (EU) 2019/6) source ↗
2026-04-24Federation of Veterinarians of EuropeCommission Expert Group on Veterinary Medicinal Products - Article 106(1) of Regulation (EU) 2019/6 source ↗
2025-12-05Bristol-Myers Squibb CompanyThe aim of the meeting was to discuss the possible improvements to the Clinical Trials Regulation, IP frameworks and cell therapy in the Biotech Act source ↗
2025-11-18Miltenyi BiotecBiotechnology and clinical trials source ↗
2025-09-04Magyarországi Klinikai Vizsgálatszervezők TársaságaPromoting multi country clinical trials source ↗
2023-10-11Gates FoundationCooperation between Bill & Melinda Gates Foundation & Commission in the European & Developing Countries Clinical Trials Partnership, Transatlantic cooperation in clean tech and Catalyst Partnership btw Breakthrough Energy, Commission and EIB source ↗
2026-07-24CSLPlasma-derived medicinal products (PDMPs) for health preparedness & emergency response source ↗
2026-04-15Asociación Agraria Jóvenes AgricultoresLumpy Skin disease (LSD) and vaccination - Veterinary medicinal products source ↗
2025-06-18CITTADINANZATTIVA APSEconomic sustainability of Advanced Therapy Medicinal Products (ATMPs) at the European level. (Meeting convened at request of interest representative following a request made to Director-General, followed up at technical level. source ↗
2025-05-27ALPHAVET Állatgyógyászati Zártkörűen Működő RészvénytársaságAnimal health and veterinary medicinal products source ↗
2022-03-17Plasma Protein Therapeutics Association Europe, international Association without lucrative purposeVTC Meeting on Blood, Tissues and Cells legislation and availability of Plasma-Derived Medicinal Products source ↗
2021-06-24European Platform for the Responsible use of medicines in animalsVTC Meeting on AMR and implementation of the new veterinary medicinal products regulation. source ↗
2025-09-04SANOFIExchange of views on multinational clinical trials in the context of the upcoming Biotech Act source ↗
2025-09-04AstraZeneca PLCExchange of views on multinational clinical trials in the context of the upcoming Biotech Act source ↗
2025-06-03Breakthrough T1DPresentation of Breakthrough T1D, the US based, tax-exempt nonprofit organisation that invests in type 1 diabetes research, and discussion on its role as a research funder supporting multicountry clinical trials within the EU source ↗
2025-05-23European Research Infrastructure for Translational MedicinePresentation of EATRIS and a discussion on their role as a clinical research infrastructure supporting multi-country clinical trials within the EU source ↗
2025-05-15European University Hospital AlliancePresentation of the EUHA and a discussion on their role as a network of clinical research hospitals supporting multi-country clinical trials within the EU. source ↗
2025-04-23Biobanking and Biomolecular resources Research Infrastructure-European Research Infrastructure ConsortiumPresentation of BBMRI-ERIC and discussion on their role as clinical research infrastructure to support multi-country clinical trials in EU source ↗
2025-02-04Eli Lilly and CompanyExchange of views on the Clinical Trials Regulation (CTR), In-Vitro Diagnostic Regulation (IVDR) and their interface. Discussion on the clinical trial environment in Europe and globally. source ↗
2020-05-25Association of European Cancer LeaguesVC meeting with discussion on access to care for cancer patients, clinical trials and research, healthcare systems in Member States during COVID-19, data collection and future funding. source ↗

Related on the graph

The same sector, mapped across the rulebook and the rest of the lobbying record.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

Rankings count distinct disclosed European Commission meetings whose topic matches the sector keywords; they are not a measure of influence or of a position taken. Methodology. Data © European Union (Decision 2011/833/EU).

See your company’s exposure on pharmaceuticals & life sciences — and the rest of the corpus.

Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.